Sanofi (NASDAQ: SNY) Set to Acquire Provention Bio (NASDAQ: PRVB) for $2.9 Billion
Provention Bio, Inc. (NASDAQ: PRVB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and ...
Provention Bio, Inc. (NASDAQ: PRVB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and ...
Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and ...
Resolute Forest Products, Inc. (NYSE: RFP) is a global leader in forest products, such as market pulp, tissue, paper, and ...
Rubicon Technology, Inc. (NASDAQ: RBCN) is a provider of monocrystalline sapphire for use in optical and industrial applications across North ...
Zendesk, Inc. (NYSE: ZEN) is engaged as a customer service and support software company, which offers a suite of services ...
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) is engaged as a specialty healthcare technology and services company, which supplies its ...
GTY Technology Holdings, Inc. (NASDAQ: GTYH) is a leader in cloud-based software solutions for the public sector. Shares of the ...
Guardforce AI Co., Limited (NASDAQ: GFAI) operates as an integrated security solutions company, which provides protective transportation services for high-value ...
Casper Sleep, Inc. (NYSE: CSPR) is engaged within the development, marketing and sale of sleep products. The company’s flagship product ...
PAE, Inc. (NASDAQ: PAE) is a global provider of operational solutions and outsourced services to the U.S. government, foreign allies, ...
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.
Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.